* An article in the Nov. 2, 1994 issue of BioWorld Today incorrectlyquoted Edmund Debler, of Mehta and Isaly in New York, on thedifficulty of drug development. The quote should have read: "Nineout of 10 products that enter Phase I fail and biotechnology hasn'tchanged that equation."
* A story in the Nov. 2 issue of BioWorld Today about the newStandard & Poor's SmallCap 600 Index did not include the followingbiotechnology-related companies, which are included in the index:Advanced Tissue Sciences Inc., Calgene Inc., CellPro Inc., CollagenCorp., COR Therapeutics Inc., Cygnus Therapeutic Systems,DEKALB Genetics Corp., Enzo Biochem Inc., Genetic Therapy Inc.,MedImmune Inc., Molecular Biosystems Inc., Mycogen Corp.,North American Vaccine Inc., PerSeptive Biosystems Inc., ProteinDesign Labs Inc., TheraTech Inc. and U.S. Bioscience Inc.
(c) 1997 American Health Consultants. All rights reserved.